- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Ketamine reduces suicidal ideation in severely depressed patients - Video
Overview
Suicidal depressed patients need rapid relief from suicidal ideation. Standard antidepressants may reduce suicidal ideation and behaviour in depressed adults, mediated by improvement in depression, but this effect takes weeks. In recent study researchers from Columbia University found that ketamine, a subanesthetic drug, improves neurocognition in patients with depression and suicidal ideation within a day. The study findings were published in the Journal of Clinical Psychiatry on November 2, 2021.
Previous studies have demonstrated that ketamine rapidly reduces depressive symptoms and suicidal ideation in some depressed patients. However, its effects on neurocognitive functioning in such individuals with significant suicidal ideation are understudied, even though certain neurocognitive deficits are associated with suicide behaviour beyond clinical symptoms. Therefore, Dr John G. Keilp, PhD and his team conducted a study to obtain a better understanding of the mechanisms behind ketamin's effect on depression and decided to examine the drug's impact on neurocognitive performance. They also compared the effectiveness of two medications, Ketamine and Midazolam, for rapidly relieving suicidal thoughts in people suffering from depression.
For more details, check out the full story at the link below:
Ketamine Swiftly Reduces Suicidal Ideation In Patients With Depression
Speakers
Dr. Nandita Mohan
BDS, MDS( Pedodontics and Preventive Dentistry)